These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 31721438)

  • 1. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
    Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
    J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.
    Li X; Liu J; Liu M; Xia C; Zhao Q
    Cell Cycle; 2020 Apr; 19(7):825-836. PubMed ID: 32106756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2/miR-212-5p/ELF3 axis.
    Wu T; Liu S; Chen W; Zhao D; Lu Z
    Int J Med Sci; 2024; 21(2):319-331. PubMed ID: 38169645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
    Lu T; Wang R; Cai H; Cui Y
    Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G; Zhu J; Liu F; Yang Y
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway.
    Zhang W; Wang Y; Xu P; Du Y; Guan W
    Dis Markers; 2022; 2022():9310048. PubMed ID: 36277988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis.
    Zhou Y; Shi H; Du Y; Zhao G; Wang X; Li Q; Liu J; Ye L; Shen Z; Guo Y; Huang Y
    Aging (Albany NY); 2019 Sep; 11(18):7386-7401. PubMed ID: 31541993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.
    Yuan S; Xiang Y; Wang G; Zhou M; Meng G; Liu Q; Hu Z; Li C; Xie W; Wu N; Wu L; Cai T; Ma X; Zhang Y; Yu Z; Bai L; Li Y
    Mol Oncol; 2019 Apr; 13(4):840-856. PubMed ID: 30614188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor
    Dong Y; Huo X; Sun R; Liu Z; Huang M; Yang S
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30287504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA DLEU2 promotes growth and invasion of hepatocellular carcinoma by regulating miR-30a-5p/PTP4A1 axis.
    Fu Y; Li B; Huang R; Ji X; Bai WK
    Pathol Res Pract; 2022 Oct; 238():154078. PubMed ID: 36049439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer.
    Zeng F; Yu N; Han Y; Ainiwaer J
    J Biosci; 2020; 45():. PubMed ID: 32345777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
    Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
    J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis.
    Pang L; Zhang Q; Wu Y; Yang Q; Zhang J; Liu Y; Li R
    Exp Biol Med (Maywood); 2021 Jan; 246(2):142-152. PubMed ID: 33023331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
    Li X; Xu F; Meng Q; Gong N; Teng Z; Xu R; Zhao M; Xia M
    Cell Death Dis; 2020 Jun; 11(6):472. PubMed ID: 32555190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p.
    Ku GW; Kang Y; Yu SL; Park J; Park S; Jeong IB; Kang MW; Son JW; Kang J
    BMC Cancer; 2021 Jan; 21(1):44. PubMed ID: 33422052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.